0000899243-22-014353.txt : 20220408 0000899243-22-014353.hdr.sgml : 20220408 20220408162749 ACCESSION NUMBER: 0000899243-22-014353 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220406 FILED AS OF DATE: 20220408 DATE AS OF CHANGE: 20220408 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chen Wei Wei CENTRAL INDEX KEY: 0001919307 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40947 FILM NUMBER: 22817349 MAIL ADDRESS: STREET 1: C/O LIANBIO STREET 2: 103 CARNEGIE CENTER DRIVE, SUITE 309 CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LianBio CENTRAL INDEX KEY: 0001831283 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 103 CARNEGIE CENTER DRIVE, SUITE 309 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: (609) 486-2308 MAIL ADDRESS: STREET 1: 103 CARNEGIE CENTER DRIVE, SUITE 309 CITY: PRINCETON STATE: NJ ZIP: 08540 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-04-06 0 0001831283 LianBio LIAN 0001919307 Chen Wei Wei C/O LIANBIO 103 CARNEGIE CENTER DRIVE, SUITE 309 PRINCETON NJ 08540 1 0 0 0 Stock Option (Right to Buy) 4.95 2022-04-06 4 A 0 72600 0.00 A 2032-04-06 Ordinary Shares 72600 72600 D 1/36 of the shares underlying the option will become exercisable on 05/06/2022; the remainder shall vest and become exercisable in 35 equal monthly installments such that the option shall be fully vested on 04/06/2025, subject to the Reporting Person providing continuous service to the Issuer on each such date. By: /s/ Angela Chen, Attorney-in-Fact 2022-04-08